NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

表紙
市場調查報告書

全球骨關節炎 (OA) 市場(關節注射、非甾體抗炎藥/非甾體抗炎藥、鎮痛藥):洞察、趨勢和預測(2021-2025)

Global Osteoarthritis Market (IA Injections, NSAIDs & Analgesics): Insights, Trends & Forecast (2021-2025)

出版商 Koncept Analytics 商品編碼 1011012
出版日期 內容資訊 英文 122 Pages
訂單完成後即時交付
價格
全球骨關節炎 (OA) 市場(關節注射、非甾體抗炎藥/非甾體抗炎藥、鎮痛藥):洞察、趨勢和預測(2021-2025) Global Osteoarthritis Market (IA Injections, NSAIDs & Analgesics): Insights, Trends & Forecast (2021-2025)
出版日期: 2021年06月14日內容資訊: 英文 122 Pages
簡介

從 2021 年到 2025 年,全球骨關節炎 (OA) 市場的收入預計將以 9.85% 的複合年增長率增長,到 2025 年將達到 109.2 億美元。骨關節炎發病率增加、老年人口增加、人均醫療費用增加、肥胖人口增加、消費者信心指數改善等因素將推動市場增長。預計會。一些值得注意的趨勢包括藥物研發支出的增加、產品管道的開發、骨關節炎治療的進步以及藥物在線銷售的增加。

本報告調查了全球骨關節炎 (OA) 市場,按地點、治療類型、分銷渠道和地區對市場規模、趨勢和市場規模進行了概述,分析了市場增長因素和挑戰以及競爭。它提供了全面的信息比如各大公司的情況和簡介。

目錄

第 1 章市場概覽

  • 簡介
  • 原因
  • 症狀學
  • 診斷
  • 治療

第 2 章全球骨關節炎 (OA) 市場分析

  • 骨關節炎市場規模
  • 骨關節炎市場規模預測
  • 骨關節炎市場規模:按網站
    • 膝關節骨關節炎的市場規模
    • 膝關節骨關節炎市場規模預測
    • 膝關節骨關節炎市場規模:按地區
  • 骨關節炎市場規模:按治療類型
    • 聯合注射 (IA) 市場規模
    • 聯合注射(IA)市場規模預測
    • 治療藥物的市場規模
    • 治療藥物市場規模預測
    • 治療藥物市場規模:按類型
    • 非甾體抗炎藥 (NSAID) 的市場規模
    • 非甾體抗炎藥 (NSAID) 市場規模預測
    • 止痛藥市場規模
    • 鎮痛藥市場規模預測
    • 治療藥物市場規模:按給藥途徑
    • 注射用藥物的市場規模
    • 腸外用藥市場規模預測
    • 口服藥物的市場規模
    • 口服藥物市場規模預測
  • 骨關節炎市場規模:按分銷渠道
  • 骨關節炎市場規模:按地區

第 3 章骨關節炎 (OA) 市場分析:按地區

  • 北美
    • 北美骨關節炎市場規模
    • 北美骨關節炎市場規模預測
    • 北美骨關節炎市場規模:按地點
    • 北美膝關節骨關節炎市場規模
    • 北美膝關節骨關節炎市場規模預測
    • 北美膝關節骨關節炎市場規模:按國家/地區
    • 美國骨關節炎市場規模
    • 美國骨關節炎市場規模預測
    • 美國骨關節炎市場規模:按治療類型
    • 美國聯合注射 (IA) 市場規模
    • 美國聯合注射 (IA) 市場規模預測
    • 美國治療藥物市場規模
    • 美國治療藥物市場規模預測
    • 美國治療藥物市場規模:按類型
    • 美國非甾體抗炎藥 (NSAID) 的市場規模
    • 美國非甾體抗炎藥 (NSAID) 市場規模預測
    • 美國止痛藥市場規模
    • 美國鎮痛藥市場規模預測
  • 歐洲
    • 歐洲骨關節炎市場
    • 歐洲骨關節炎市場規模預測
    • 歐洲骨關節炎市場:按地點
    • 歐洲膝關節骨關節炎市場
    • 歐洲膝關節骨關節炎市場規模預測
  • 亞太地區
    • 亞太地區骨關節炎市場
    • 亞太地區骨關節炎市場規模預測
    • 亞太地區骨關節炎市場:按地點
    • 亞太地區膝關節骨關節炎市場規模
    • 亞太地區膝骨關節炎市場規模預測

第 4 章市場動態

  • 增長因素
    • 骨關節炎的發病率增加
    • 老年人口增加
    • 人均醫療費用增加
    • 肥胖人口不斷增加
    • 消費者信心指數改善
  • 主要趨勢和發展
    • 醫藥產品研發費用增長
    • 漸進式產品線
    • 骨關節炎治療進展
    • 在線藥品銷售增長
  • 挑戰
    • 相關業務風險
    • 與患者健康相關的風險
    • 嚴格的規定

第 5 章競爭形勢

  • 全球骨關節炎市場
    • 各大公司利潤對比
    • 各大公司市值對比
    • 各大公司研發費用對比

第 6 章公司簡介

  • Johnson & Johnson
  • Novartis AG
  • Bayer AG
  • GlaxoSmithKline Plc
  • Pfizer Inc.
  • Sanofi S.A.
目錄

The global osteoarthritis market revenues are forecasted to touch US$10.92 billion in 2025, growing at a CAGR of 9.85% for the period spanning from 2021 to 2025.

Factors such as increasing occurrence of osteoarthritis, growing geriatric population, rising healthcare expenditure per capita, growing obese population and improving consumer confidence index are expected to drive the market growth. However, growth of the industry would be challenged by associated business risk, patient health-associated risk and stringent regulations. A few notable trends include growth in pharmaceutical R&D expenditures, progressing product pipeline, advancement in osteoarthritis treatments and growth in online pharmaceutical sales.

In 2020, the outbreak of COVID-19 pandemic has created an unfavorable impact on the market as the osteoarthritis therapeutics sales declined during Q1-2020.

The global osteoarthritis market by treatment type is segmented into categories i.e. IA Injections (corticosteroids and HA) and Drugs (NSAIDs & Analgesics). Among them, IA injections held the largest share of the industry revenues due to growth in prevalence of joint disorders across the world.

The fastest growing regional market is North America. The growth was supported by growth in geriatric population, surge in HA injections demand, rise in sports injuries and development in e-commerce industry. The U.S. is the largest market and is already well-penetrated at developed market levels

Scope of the report:

  • The report provides a comprehensive analysis of the global osteoarthritis market, segmented into IA Injections and Drugs (Analgesics and NSAIDs).
  • The major regional markets (North America, Europe and Asia-Pacific) have been analysed along with country coverage of US.
  • The market dynamics such as growth drivers, market trends and challenges are analysed in-depth.
  • The competitive landscape of the market, along with the company profiles of leading players i.e. Johnson & Johnson, Novartis AG, Bayer AG, GlaxoSmithKline Plc, Pfizer Inc. and Sanofi S.A. are also presented in detail.

Key Target Audience:

  • Osteoarthritis Therapeutics Manufacturers
  • Ingredient Suppliers
  • End Users
  • Consulting Firms
  • Investment Banks
  • Government Bodies & Regulating Authorities

Table of Contents

1. Market Overview

  • 1.1 Introduction
  • 1.2 Causes
  • 1.3 Symptoms
  • 1.4 Diagnosis
  • 1.5 Treatment

2. Global Osteoarthritis Market Analysis

  • 2.1 Global Osteoarthritis Market Value
  • 2.2 Global Osteoarthritis Market Value Forecast
  • 2.3 Global Osteoarthritis Market Value by Anatomy Type
    • 2.3.1 Global Knee Osteoarthritis Market Value
    • 2.3.2 Global Knee Osteoarthritis Market Value Forecast
    • 2.3.3 Global Knee Osteoarthritis Market Value by Region
  • 2.4 Global Osteoarthritis Market Value by Treatment Type
    • 2.4.1 Global Osteoarthritis IA Injections Market Value
    • 2.4.2 Global Osteoarthritis IA Injections Market Value Forecast
    • 2.4.3 Global Osteoarthritis Drugs Market Value
    • 2.4.4 Global Osteoarthritis Drugs Market Value Forecast
    • 2.4.5 Global Osteoarthritis Drugs Market Value by Type
    • 2.4.6 Global Osteoarthritis NSAIDs Market Value
    • 2.4.7 Global Osteoarthritis NSAIDs Market Value Forecast
    • 2.4.8 Global Osteoarthritis Analgesics Market Value
    • 2.4.9 Global Osteoarthritis Analgesics Market Value Forecast
    • 2.4.10 Global Osteoarthritis Drugs Market Value by Route of Administration
    • 2.4.11 Global Osteoarthritis Parenteral Drugs Market Value
    • 2.4.12 Global Osteoarthritis Parenteral Drugs Market Value Forecast
    • 2.4.13 Global Osteoarthritis Oral Drugs Market Value
    • 2.4.14 Global Osteoarthritis Oral Drugs Market Value Forecast
  • 2.5 Global Osteoarthritis Market Value by Distribution Channels
  • 2.6 Global Osteoarthritis Market Value by Region

3. Regional Osteoarthritis Market Analysis

  • 3.1 North America
    • 3.1.1 North America Osteoarthritis Market Value
    • 3.1.2 North America Osteoarthritis Market Value Forecast
    • 3.1.3 North America Osteoarthritis Market Value by Anatomy Type
    • 3.1.4 North America Knee Osteoarthritis Market Value
    • 3.1.5 North America Knee Osteoarthritis Market Value Forecast
    • 3.1.6 North America Osteoarthritis Market Value by Country
    • 3.1.7 The U.S. Osteoarthritis Market Value
    • 3.1.8 The U.S. Osteoarthritis Market Value Forecast
    • 3.1.9 The U.S. Osteoarthritis Market Value by Treatment Type
    • 3.1.10 The U.S. Osteoarthritis IA Injections Market Value
    • 3.1.11 The U.S. Osteoarthritis IA Injections Market Value Forecast
    • 3.1.12 The U.S. Osteoarthritis Drugs Market Value
    • 3.1.13 The U.S. Osteoarthritis Drugs Market Value Forecast
    • 3.1.14 The U.S. Osteoarthritis Drugs Market Value by Type
    • 3.1.15 The U.S. Osteoarthritis NSAIDs Market Value
    • 3.1.16 The U.S. Osteoarthritis NSAIDs Market Value Forecast
    • 3.1.17 The U.S. Osteoarthritis Analgesics Market Value
    • 3.1.18 The U.S. Osteoarthritis Analgesics Market Value Forecast
  • 3.2 Europe
    • 3.2.1 Europe Osteoarthritis Market Value
    • 3.2.2 Europe Osteoarthritis Market Value Forecast
    • 3.2.3 Europe Osteoarthritis Market Value by Anatomy Type
    • 3.2.4 Europe Knee Osteoarthritis Market Value
    • 3.2.5 Europe Knee Osteoarthritis Market Value Forecast
  • 3.3 Asia-Pacific
    • 3.3.1 Asia-Pacific Osteoarthritis Market Value
    • 3.3.2 Asia-Pacific Osteoarthritis Market Value Forecast
    • 3.3.3 Asia-Pacific Osteoarthritis Market Value by Anatomy Type
    • 3.3.4 Asia-Pacific Knee Osteoarthritis Market Value
    • 3.3.5 Asia-Pacific Knee Osteoarthritis Market Value Forecast

4. Market Dynamics

  • 4.1 Growth Drivers
    • 4.1.1 Inclining Occurrence of Osteoarthritis
    • 4.1.2 Growing Geriatric Population
    • 4.1.3 Rising Healthcare Expenditure per Capita
    • 4.1.4 Growing Obese Population
    • 4.1.5 Improving Consumer Confidence Index
  • 4.2 Key Trends and Developments
    • 4.2.1 Growth in Pharmaceutical R&D Expenditures
    • 4.2.2 Progressing Product Pipeline
    • 4.2.3 Advancement in Osteoarthritis Treatments
    • 4.2.4 Growth in Online Pharmaceutical Sales
  • 4.3 Challenges
    • 4.3.1 Associated Business Risk
    • 4.3.2 Patient Health-Associated Risk
    • 4.3.3 Stringent Regulations

5. Competitive Landscape

  • 5.1 Global Osteoarthritis Market
    • 5.1.1 Key Players - Revenues Comparison
    • 5.1.2 Key Players - Market Cap Comparison
    • 5.1.3 Key Players - R&D Expenditures Comparison

6. Company Profiles

  • 6.1 Johnson & Johnson
    • 6.1.1 Business Overview
    • 6.1.2 Financial Overview
    • 6.1.3 Business Strategies
  • 6.2 Novartis AG
    • 6.2.1 Business Overview
    • 6.2.2 Financial Overview
    • 6.2.3 Business Strategies
  • 6.3 Bayer AG
    • 6.3.1 Business Overview
    • 6.3.2 Financial Overview
    • 6.3.3 Business Strategies
  • 6.4 GlaxoSmithKline Plc
    • 6.4.1 Business Overview
    • 6.4.2 Financial Overview
    • 6.4.3 Business Strategies
  • 6.5 Pfizer Inc.
    • 6.5.1 Business Overview
    • 6.5.2 Financial Overview
    • 6.5.3 Business Strategies
  • 6.6 Sanofi S.A.
    • 6.6.1 Business Overview
    • 6.6.2 Financial Overview
    • 6.6.3 Business Strategies

List of Figures

  • Global Osteoarthritis Market Value (2016-2020)
  • Global Osteoarthritis Market Value Forecast (2021-2025)
  • Global Osteoarthritis Market Value by Anatomy Type (2020)
  • Global Knee Osteoarthritis Market Value (2016-2020)
  • Global Knee Osteoarthritis Market Value Forecast (2021-2025)
  • Global Knee Osteoarthritis Market Value by Region (2020)
  • Global Osteoarthritis Market Value by Treatment Type (2020)
  • Global Osteoarthritis IA Injections Market Value (2016-2020)
  • Global Osteoarthritis IA Injections Market Value Forecast (2021-2025)
  • Global Osteoarthritis Drugs Market Value (2016-2020)
  • Global Osteoarthritis Drugs Market Value Forecast (2021-2025)
  • Global Osteoarthritis Drugs Market Value by Type (2020)
  • Global Osteoarthritis NSAIDs Market Value (2016-2020)
  • Global Osteoarthritis NSAIDs Market Value Forecast (2021-2025)
  • Global Osteoarthritis Analgesics Market Value (2016-2020)
  • Global Osteoarthritis Analgesics Market Value Forecast (2021-2025)
  • Global Osteoarthritis Drugs Market Value by Route of Administration (2020)
  • Global Osteoarthritis Parenteral Drugs Market Value (2016-2020)
  • Global Osteoarthritis Parenteral Drugs Market Value Forecast (2021-2025)
  • Global Osteoarthritis Oral Drugs Market Value (2016-2020)
  • Global Osteoarthritis Oral Drugs Market Value Forecast (2021-2025)
  • Global Osteoarthritis Market Value by Distribution Channels (2020)
  • Global Osteoarthritis Market Value by Region (2020)
  • North America Osteoarthritis Market Value (2016-2020)
  • North America Osteoarthritis Market Value Forecast (2021-2025)
  • North America Osteoarthritis Market Value by Anatomy Type (2020)
  • North America Knee Osteoarthritis Market Value (2016-2020)
  • North America Osteoarthritis Market Value Forecast (2021-2025)
  • North America Osteoarthritis Market Value by Country (2020)
  • The U.S. Osteoarthritis Market Value (2016-2020)
  • The U.S. Osteoarthritis Market Value Forecast (2021-2025)
  • The U.S. Osteoarthritis Market Value by Treatment Type (2020)
  • The U.S. Osteoarthritis IA Injections Market Value (2016-2020)
  • The U.S. Osteoarthritis IA Injections Market Value Forecast (2021-2025)
  • The U.S. Osteoarthritis Drugs Market Value (2016-2020)
  • The U.S. Osteoarthritis Drugs Market Value Forecast (2021-2025)
  • The U.S. Osteoarthritis Drugs Market Value by Type (2020)
  • The U.S. Osteoarthritis NSAIDs Market Value (2016-2020)
  • The U.S. Osteoarthritis NSAIDs Market Value Forecast (2021-2025)
  • The U.S. Osteoarthritis Analgesics Market Value (2016-2020)
  • The U.S. Osteoarthritis Analgesics Market Value Forecast (2021-2025)
  • Europe Osteoarthritis Market Value (2016-2020)
  • Europe Osteoarthritis Market Value Forecast (2021-2025)
  • Europe Osteoarthritis Market Value by Anatomy Type (2020)
  • Europe Knee Osteoarthritis Market Value (2016-2020)
  • Europe Knee Osteoarthritis Market Value Forecast (2021-2025)
  • Asia-Pacific Osteoarthritis Market Value (2016-2020)
  • Asia-Pacific Osteoarthritis Market Value Forecast (2021-2025)
  • Asia-Pacific Osteoarthritis Market Value by Anatomy Type (2020)
  • Asia-Pacific Knee Osteoarthritis Market Value (2016-2020)
  • Asia-Pacific Knee Osteoarthritis Market Value Forecast (2021-2025)
  • Global Osteoarthritis Population (2016-2020)
  • Global Geriatric Population (2016-2020)
  • Global Healthcare Expenditure per Capita (2016-2020)
  • The U.S. Obese Population (2016-2020)
  • Consumer Confidence Index in US and Europe (2016-2020)
  • Global Pharmaceutical R&D Expenditures (2016-2020)
  • Global Online Pharmaceutical Sales (2020-2025)
  • Key Players - Market Cap Comparison
  • Key Players - R&D Expenditures Comparison (2019/2020)
  • J&J Sales and Earnings (2016-2020)
  • J&J Sales by Segments (2020)
  • Novartis Net Sales and Net Income (2016-2020)
  • Novartis Net Sales by Segments (2020)
  • Bayer Net Sales and Net Income (Loss) (2016-2020)
  • Bayer Net Sales by Segments (2020)
  • GSK Turnover and Profit (2016-2020)
  • GSK Turnover by Segment (2020)
  • GSK Turnover by Region (2020)
  • Pfizer Revenues and Net Income (2016-2020)
  • Pfizer Revenues by Region (2020)
  • Sanofi Net Sales and Net Income (2016-2020)
  • Sanofi Net Sales by Segments (2020)
  • Sanofi Net Sales by Region (2020)
  • Key Players - Revenues Comparison (2020)